Skip to main content
SpringerLink
Log in

Evaluation of Granulated Lactose as a Carrier for DPI Formulations 1: Effect of Granule Size

  • Research Article
  • Theme: Advances in Formulation and Device Technologies for Pulmonary Drug Delivery
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

ABSTRACT

The objective of this study was to investigate the effect of large granulated lactose carrier particle systems on aerosol performance of dry powder inhaler formulations. Granulated lactose carriers with average sizes ranging from 200 to 1,000 μm were prepared and subsequently fractionated into separate narrow size powders. The fractionated granulated lactose (GL) samples were characterized in terms of size, specific surface area, surface roughness, morphology, density, flowability, and solid-state. The in vitro aerosolization performance was performed on the different size fractions of GL samples from a commercial inhaler device (Aerolizer®) with a model formulation (2% w/w salbutamol sulfate). The cascade impaction parameters employed were 60 or 90 L/min with standard (aperture size, 0.6 mm) or modified piercing holes (aperture size, 1.2 mm) of the inhaler loaded capsules. It was shown that the largest size fraction formulation (850–1000 μm) had a slight improvement in the fine particle fraction (FPF) compared to immediately preceding size fractions, explained by a smaller adhesive force between drug and carrier. Compared to commercial piercing holes, enlarged piercing holes generated a slight decreasing trend of FPF as the lactose powder sizes increased from 200–250 μm to 600–850 μm, perhaps due to the reduced detachment force by flow forces. The size, surface roughness, density, and flowability of lactose carrier as well as device design all contributed to the aerosol dispersion performance of granulated lactose-based adhesive mixtures. It was concluded that poorer or enhanced redispersion performance is not an inherent property to the significantly large size of granulated lactose carriers as previously contended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Hickey AJ. Pharmaceutical inhalation aerosol powder dispersion—an unbalancing act. Am Pharm Rev. 2003;6:106–10.

    CAS  Google Scholar 

  2. Smyth HD, Hickey AJ. Carriers in drug powder delivery. Am J Drug Deliv. 2005;3:117–32.

    Article  CAS  Google Scholar 

  3. Adi H, Larson I, Stewart PJ. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation. Int J Pharm. 2007;337:229–38.

    Article  CAS  PubMed  Google Scholar 

  4. Steckel H, Muller BW. In vitro evaluation of dry powder inhalers. 2. Influence of carrier particle size and concentration on in vitro deposition. Int J Pharm. 1997;154:31–7.

    Article  CAS  Google Scholar 

  5. Flament MP, Leterme P, Gayot A. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. Int J Pharm. 2004;275:201–9.

    Article  CAS  PubMed  Google Scholar 

  6. Pitchayajittipong C, Price R, Shur J, Kaerger JS, Edge S. Characterisation and functionality of inhalation anhydrous lactose. Int J Pharm. 2010;390:134–41.

    Article  CAS  PubMed  Google Scholar 

  7. Jiang RG, Zhang PW, Wang LQ, Liu H, Pan WS, Wang CL. Effect of surface modification on surface energy of lactose and performance of dry powder inhalations. Yao Xue Xue Bao. 2005;40:373–6.

    CAS  PubMed  Google Scholar 

  8. Guenette E, Barrett A, Kraus D, Brody R, Harding L, Magee G. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design. Int J Pharm. 2009;380:80–8.

    Article  CAS  PubMed  Google Scholar 

  9. Kougoulos E, Marziano I, Miller PR. Lactose particle engineering: Influence of ultrasound and anti-solvent on crystal habit and particle size. J Cryst Growth 312:3509–20.

  10. Ferrari F, Cocconi D, Bettini R, Giordano F, Santi P, Tobyn M, et al. The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer. AAPS PharmSciTech. 2004;5:e60.

    Article  PubMed  Google Scholar 

  11. de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW. Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures. Int J Pharm. 2003;260:187–200.

    Article  PubMed  Google Scholar 

  12. Voss A, Finlay WH. Deagglomeration of dry powder pharmaceutical aerosols. Int J Pharm. 2002;248:39–50.

    Article  CAS  PubMed  Google Scholar 

  13. Donovan MJ, Smyth HD. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations. Int J Pharm. 2010;402:1–9.

    Article  CAS  PubMed  Google Scholar 

  14. Dickhoff BH, de Boer AH, Lambregts D, Frijlink HW. The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation. Eur J Pharm Biopharm. 2005;59:197–205.

    Article  CAS  PubMed  Google Scholar 

  15. Grasmeijer F, Hagedoorn P, Frijlink HW, de Boer AH. Drug content effects on the dispersion performance of adhesive mixtures for inhalation. PLoS One. 2013;8:e71339.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Islam N, Stewart P, Larson I, Hartley P. Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharm Res. 2004;21:492–9.

    Article  CAS  PubMed  Google Scholar 

  17. Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HD, Mulder T, et al. Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics. J Pharm Sci. 2007;96:1282–301.

    Article  CAS  PubMed  Google Scholar 

  18. de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Kussendrager KD, Frijlink HW. Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation. Int J Pharm. 2003;260:201–16.

    Article  PubMed  Google Scholar 

  19. Louey MD, Razia S, Stewart PJ. Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int J Pharm. 2003;252:87–98.

    Article  CAS  PubMed  Google Scholar 

  20. Cline D, Dalby R. Predicting the quality of powders for inhalation from surface energy and area. Pharm Res. 2002;19:1274–7.

    Article  CAS  PubMed  Google Scholar 

  21. Donovan MJ, Kim SH, Raman V, Smyth HD. Dry powder inhaler device influence on carrier particle performance. J Pharm Sci. 2012;101:1097–107.

    Article  CAS  PubMed  Google Scholar 

  22. Littringer EM, Mescher A, Schroettner H, Achelis L, Walzel P, Urbanetz NA. Spray dried mannitol carrier particles with tailored surface properties—the influence of carrier surface roughness and shape. Eur J Pharm Biopharm. 2012;82:194–204.

    Article  CAS  PubMed  Google Scholar 

  23. Kawashima Y, Serigano T, Hino T, Yamamoto H, Takeuchi H. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. 1998;172:188.

  24. Li J, Tao L, Buckley D, Tao J, Gao J, Hubert M. The effect of the physical state of binders on high-shear wet granulation and granule properties: a mechanistic approach to understand the high-shear wet granulation process. Part IV. The impact of rheological state and tip-speeds. J Pharm Sci. 2013;102:4384–94.

    Article  CAS  PubMed  Google Scholar 

  25. Fujiwara M, Dohi M, Otsuka T, Yamashita K, Sako K. Influence of binder droplet dimension on granulation rate during fluidized bed granulation. Chem Pharm Bull (Tokyo). 2013;61:320–5.

    Article  CAS  Google Scholar 

  26. Ogawa T, Uchino T, Takahashi D, Izumi T, Otsuka M. Pharmaceutical production of tableting granules in an ultra-small-scale high-shear granulator as a pre-formulation study. Drug Dev Ind Pharm. 2012;38:1390–3.

    Article  CAS  PubMed  Google Scholar 

  27. Mangwandi C, Adams MJ, Hounslow MJ, Salman AD. An investigation of the influence of process and formulation variables on mechanical properties of high shear granules using design of experiment. Int J Pharm. 2012;427:328–36.

    Article  CAS  PubMed  Google Scholar 

  28. Singh I, Kumar P. Preformulation studies for direct compression suitability of cefuroxime axetil and paracetamol: a graphical representation using SeDeM diagram. Acta Pol Pharm. 2012;69:87–93.

    CAS  PubMed  Google Scholar 

  29. Coates MS, Fletcher DF, Chan HK, Raper JA. The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses. Pharm Res. 2005;22:923–32.

    Article  CAS  PubMed  Google Scholar 

  30. Zeng XM, Martin GP, Marriott C, Pritchard J. The influence of crystallization conditions on the morphology of lactose intended for use as a carrier for dry powder aerosols. J Pharm Pharmacol. 2000;52:633–43.

    Article  CAS  PubMed  Google Scholar 

  31. Li X, Mansour HM. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery. AAPS PharmSciTech. 2011;12:1420–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Kaialy W, Ticehurst MD, Murphy J, Nokhodchi A. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone. J Pharm Sci. 2011;100:2665–84.

    Article  CAS  PubMed  Google Scholar 

  33. Adi S, Adi H, Tang P, Traini D, Chan HK, Young PM. Micro-particle corrugation, adhesion and inhalation aerosol efficiency. Eur J Pharm Sci. 2008;35:12–8.

    Article  CAS  PubMed  Google Scholar 

  34. Adi H, Traini D, Chan HK, Young PM. The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations. J Pharm Sci. 2008;97:2780–8.

    Article  CAS  PubMed  Google Scholar 

  35. Islam N, Stewart P, Larson I, Hartley P. Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy. J Pharm Sci. 2005;94:1500–11.

    Article  CAS  PubMed  Google Scholar 

  36. Young PM, Edge S, Traini D, Jones MD, Price R, El-Sabawi D, et al. The influence of dose on the performance of dry powder inhalation systems. Int J Pharm. 2005;296:26–33.

    Article  CAS  PubMed  Google Scholar 

  37. Kaialy W, Martin GP, Larhrib H, Ticehurst MD, Kolosionek E, Nokhodchi A. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers. Colloids Surf B: Biointerfaces. 2012;89:29–39.

    Article  CAS  PubMed  Google Scholar 

  38. Sinko PJ. Martin’s physical pharmacy and pharmaceutical sciences. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  39. Dickhoff BH, de Boer AH, Lambregts D, Frijlink HW. The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time. Eur J Pharm Biopharm. 2003;56:291–302.

    Article  CAS  PubMed  Google Scholar 

  40. Liu LX, Marziano I, Bentham AC, Litster JD, White ET, Howes T. Effect of particle properties on the flowability of ibuprofen powders. Int J Pharm. 2008;362:109–17.

    Article  CAS  PubMed  Google Scholar 

  41. Kaialy W, Hussain T, Alhalaweh A, Nokhodchi A. Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres. Pharm Res. 2013.

  42. Chew NYK, Bagster DF, Chan HK. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. Int J Pharm. 2000;206:75–83.

    Article  CAS  PubMed  Google Scholar 

  43. de Boer AH, Chan HK, Price R. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect? Adv Drug Deliv Rev. 2012;64:257–74.

    Article  PubMed  Google Scholar 

  44. Podczeck F. Assessment of the mode of adherence and the deformation characteristics of micronized particles adhering to various surfaces. Int J Pharm. 1996;145:65–76.

    Article  CAS  Google Scholar 

  45. Le VN, Hoang Thi TH, Robins E, Flament MP. Dry powder inhalers: Study of the parameters influencing adhesion and dispersion of fluticasone propionate. AAPS PharmSciTech. 2012;13:477–84.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Concessio NM, VanOort MM, Knowles MR, Hickey AJ. Pharmaceutical dry powder aerosols: Correlation of powder properties with dose delivery and implications for pharmacodynamic effect. Pharm Res. 1999;16:828–34.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest

The authors report no conflicts of interest.

Author information

Authors and Affiliations

  1. College of Pharmacy, Division of Pharmaceutics, The University of Texas at Austin, 1 University Station, A1900, Austin, Texas, 78712-1200, USA

    Ping Du, Ju Du & Hugh D. C. Smyth

Authors
  1. Ping Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ju Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hugh D. C. Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hugh D. C. Smyth.

Additional information

Guest Editors: Paul B. Myrdal and Steve W. Stein

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Du, P., Du, J. & Smyth, H.D.C. Evaluation of Granulated Lactose as a Carrier for DPI Formulations 1: Effect of Granule Size. AAPS PharmSciTech 15, 1417–1428 (2014). https://doi.org/10.1208/s12249-014-0166-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-014-0166-z

KEY WORDS

Search

Navigation